Digestive & Intestinal Remedies (Pharmacies) - ASEAN

  • ASEAN
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$0.96bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.42%, resulting in a market volume of US$1.25bn by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.39 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in ASEAN is experiencing significant growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
Customers in the ASEAN region are increasingly seeking digestive and intestinal remedies to address common gastrointestinal issues such as indigestion, bloating, and constipation. This is driven by factors such as changing dietary habits, sedentary lifestyles, and increasing awareness about the importance of gut health. Additionally, the rising prevalence of digestive disorders and gastrointestinal diseases is also contributing to the growing demand for these remedies.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in ASEAN is the growing popularity of natural and herbal remedies. Customers are increasingly opting for products that are perceived to be safer and have fewer side effects. This trend is driven by the rising awareness about the potential risks associated with long-term use of conventional medications. As a result, there is a growing demand for natural ingredients such as ginger, peppermint, and turmeric, which are known for their digestive health benefits. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive and intestinal remedies in pharmacies. This allows customers to easily access these products without the need for a prescription. The convenience and affordability of OTC remedies are driving their popularity among consumers, especially those who prefer self-medication for minor digestive issues.

Local special circumstances:
In the ASEAN region, there is a growing aging population, which is more prone to digestive problems and gastrointestinal disorders. This demographic trend is fueling the demand for digestive and intestinal remedies. Additionally, the region's diverse culinary traditions and spicy foods are known to contribute to digestive issues, creating a need for effective remedies.

Underlying macroeconomic factors:
The growing middle-class population and increasing disposable incomes in the ASEAN region are driving the demand for healthcare products, including digestive and intestinal remedies. As people become more health-conscious, they are willing to spend more on products that can improve their overall well-being. Furthermore, the expanding pharmaceutical industry in ASEAN countries is providing a wide range of options for customers to choose from, further driving market growth. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in ASEAN is witnessing growth due to changing customer preferences, emerging trends such as the popularity of natural remedies, and local special circumstances such as the aging population and diverse culinary traditions. These factors, coupled with the region's growing middle-class population and increasing disposable incomes, are driving the demand for digestive and intestinal remedies.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)